Clinical Trial Update: Risk of Urinary Retention With Retigabine

View source ↗

Summary

A terminated GlaxoSmithKline-sponsored trial evaluating retigabine in epilepsy has raised concerns about urinary retention. The update highlights a potential sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Retigabine (ezogabine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Status: TERMINATED